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Question: Are intraoperative heart rate and/or systolic blood pressure associated 
with myocardial injury after non-cardiac surgery (MINS)? 
 
Findings: Very high heart rate and very high or low systolic blood pressure during 
surgery are associated with increased risk of MINS. 
 
Meaning: Further targeted interventional studies using intraoperative heart rate 
and/or blood pressure thresholds that we have identified may help identify 








The association between intraoperative cardiovascular changes and perioperative 
myocardial injury has chiefly focused on hypotension during non-cardiac surgery. 
However, the relative influence of blood pressure and heart rate remains unclear. We 
investigated both individual and co-dependent relationships between intraoperative heart 




Secondary analysis of the VISION study, a prospective international cohort study of non-
cardiac surgical patients. Multivariable logistic regression analysis tested for associations 
between intraoperative HR and/or SBP and MINS, defined by an elevated serum 
troponin T adjudicated as due to an ischaemic aetiology, within 30 days after surgery. 
Pre-defined thresholds for intraoperative HR and SBP were: maximum HR >100 beats or 
minimum HR <55 per minute (bpm); maximum SBP >160 mmHg or minimum SBP <100 




After excluding missing data, 1,197/15,109 patients (7.9%) sustained MINS, 454/16,031 
(2.8%) sustained myocardial infarction and 315/16,061 patients (2.0%) died within 30 
days after surgery. Maximum intraoperative HR >100 bpm was associated with MINS 
(OR 1.27 [1.07–1.50]; p<0.01), myocardial infarction (OR 1.34 [1.05-1.70]; p=0.02) and 
mortality (OR 2.65 [2.06-3.41]; p<0.01). Minimum SBP <100 mmHg was associated with 
MINS (OR 1.21 [1.05–1.39]; p=0.01) and mortality (OR 1.81 [1.39-2.37]; p<0.01), but not 
myocardial infarction (OR 1.21 [0.98-1.49]; p=0.07). Maximum SBP >160 mmHg was 
associated with MINS (OR 1.16 [1.01–1.34]; p=0.04) and myocardial infarction (OR 1.34 
[1.09-1.64]; p=0.01) but, paradoxically, reduced mortality (OR 0.76 [0.58-0.99]; p=0.04). 
Minimum HR<55 bpm was associated with reduced MINS (OR 0.70 [0.59 – 0.82]; 
p<0.01), myocardial infarction (OR 0.75 [0.58-0.97]; p=0.03) and mortality (OR 0.58 
[0.41-0.81]; p<0.01). Minimum SBP <100mmHg with maximum HR >100 bpm was more 
strongly associated with MINS (OR 1.42 (1.15-1.76); p<0.01) compared with minimum 





Intraoperative tachycardia and hypotension are associated with MINS. Further 
interventional research targeting heart rate/blood pressure is needed to define the 




One in ten patients sustain myocardial injury after non-cardiac surgery (MINS),1 
characterized by a transient rise in serum troponin levels usually unaccompanied by any 
clinical or electrocardiographic signs/symptoms.2 Postoperative troponin elevation is 
strongly associated with death after surgery, which occurs in up to 1-4% of eight million 
surgical procedures carried out in the United Kingdom each year.1, 3-5 Although the 
aetiology of MINS remains unclear,6 numerous retrospective studies implicate extreme 
intraoperative changes in blood pressure and/or heart rate.7, 8 However, few of these 
studies have used an objective, subclinical marker of MINS. 
 
Tachycardia and hypotension, either separately or in combination, may provoke MINS, 
via a presumed mechanism of oxygen supply-demand-imbalance.7-10 Although 
preoperative resting heart rate is associated with postoperative MINS, it is uncertain if 
this relationship continues during surgery.11 Attempts to control elevated heart rate with 
beta-blockers have consistently demonstrated a reduction in myocardial infarction; 
however, trials have also demonstrated an increase in mortality and stroke with 
perioperative beta-blocker treatment.12, 13 Moreover, the impact of the combination of 
intraoperative tachycardia and hypotension on MINS remains unclear. Similarly, how the 
duration of hemodynamic abnormalities influence the development of MINS is uncertain 
and under-investigated.14-17  
 
In the largest prospective perioperative cohort of its kind, we tested whether high or low 
intraoperative heart rate or systolic blood pressure, in isolation or combination, were 
associated with MINS, myocardial infarction or mortality within 30 days after non-cardiac 
surgery in the VISION study cohort. In addition, we tested whether the duration of high 
or low heart rate/systolic blood pressure was associated with MINS within 30 days of 





This was a secondary analysis of a prospective international observational cohort study, 
the Vascular Events in Non-cardiac Surgery Cohort Evaluation (VISION) study.1 The 
methods have been published previously and the study was registered with 
clinicaltrials.gov (NCT00512109).1, 11, 18, 19 This analysis was planned before taking 
custody of data; exposures and outcomes were defined a priori. Ethics committees or 
institutional review boards at each site reviewed and approved the protocol, and the 
research was consistent with the principles of the declaration of Helsinki. All participants 
or their designates provided written informed consent to take part in the study. Eight 
hospitals used deferred consent for patients who were unable to provide consent and 
had no next of kin available. Where it was not possible to approach the patient before 
surgery (e.g. emergency surgery), they were approached for written consent within 24 




VISION study participants were aged 45 years or older, underwent non-cardiac surgery 
under general or regional anaesthesia, and stayed in hospital for at least one night. 
Patients were excluded if they refused to provide consent or if they had previously taken 
part in the VISION study.  
 
Data collection 
Data were collected prospectively by research personnel at each hospital before, during 
and after surgery. There was a follow-up visit or telephone call at 30 days after surgery. 
Medical records were reviewed prospectively and data were transcribed to standardized 





Clinical staff measured heart rate and blood pressure before and during surgery as part 
of routine medical care according to local practice. Blood pressure was most often 
measured using the oscillometric, non-invasive, technique. During surgery the highest 
and lowest single measurements of heart rate and systolic blood pressure, duration of 
heart rate >100 bpm and <55 bpm, and duration of systolic blood pressure >160 mmHg 
and <100 mmHg, were recorded by reviewing the anesthetic charts or record. Duration 
was defined as the total time above or below the pre-defined thresholds during surgery, 
measured in minutes. Predefined and pragmatic thresholds for heart rate and blood 
pressure were chosen prospectively by consensus of VISION study investigators.  
 
Outcome measures 
The primary outcome measure was myocardial injury after non-cardiac surgery (MINS), 
according to the VISION study definition: serum Troponin T (TnT) ≥0.03ng/mL within 30 
days after surgery, adjudicated as due to an ischemic pathology, which excludes non-
ischemic causes of transient troponin elevation.19, 21 TnT was measured using a Roche 
4th generation ElecsysTM assay. Blood was sampled between six and twelve hours after 
surgery was completed, and then again on postoperative days one, two and three. In 
addition, investigators were encouraged to take additional blood samples if participants 
experienced an ischemic symptom within the 30-day postoperative period. Since TnT 
≥0.04ng/mL was the accepted laboratory threshold at many hospitals when the study 
started, electrocardiograms were only routinely performed when troponin concentration 
reached this threshold. Echocardiograms were recommended in the absence of clinical 
signs or electrocardiographic evidence of myocardial ischemia. Patients with a serum 
troponin elevation <0.04 ng/mL were not investigated for evidence of myocardial 
ischemia. The secondary outcome was myocardial infarction within 30 days of surgery. 
Myocardial infarction was defined according to the third universal definition (serum 
troponin elevation in the presence of at least one of: ischemic symptoms; the 
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development of new or presumed new Q waves, ST segment or T wave changes, or left 
bundle branch block on the electrocardiogram; or the finding of a new or presumed new 
regional wall motion abnormality on echocardiography).22 The tertiary outcome measure 
was all-cause mortality within 30 days after surgery. 
 
Statistical analysis 
We used SPSS (IBM, New York) for the primary analysis, which we planned before 
taking custody of the data. Cases that were missing a record of highest or lowest 
intraoperative heart rate or systolic blood pressure, or outcome data were excluded from 
respective analyses by list-wise deletion (figure 1). We sorted and dichotomized the 
sample according to predefined thresholds for highest intraoperative heart rate (>100 
bpm), lowest intraoperative heart rate (<55 bpm), highest intraoperative systolic blood 
pressure (>160 mmHg) and lowest intraoperative systolic blood pressure (<100 mmHg), 
and considered these as categorical variables. We presented demographic data 
stratified according to these groups.  Continuous data that followed a normal distribution 
were presented as mean (standard deviation), continuous data that did not follow a 
normal distribution were presented as median (interquartile range), and binary 
categorical data as frequencies with percentages.  
 
We used multivariable logistic regression analysis to test for associations between 
independent variables and MINS within 30 days after surgery. The reference groups 
were: heart rate ≤100 bpm for highest heart rate, heart rate ≥55 bpm for lowest heart 
rate, systolic blood pressure ≤160 mmHg for highest systolic pressure and systolic blood 
pressure ≥100 mmHg for lowest systolic pressure. Each multivariable model was 
adjusted for potentially confounding factors known to be associated with MINS, 
cardiovascular complications or mortality in other perioperative research: age (45-64, 65-
75, >75 years), current atrial fibrillation, diabetes, hypertension, heart failure, coronary 
artery disease, peripheral vascular disease, previous stroke or transient ischemic attack, 
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estimated glomerular filtration rate (eGFR <30, 30-44, 45-60, >60 ml/min), chronic 
obstructive pulmonary disease, neurosurgery, major surgery and urgent/emergency 
surgery were considered as categorical variables in the multivariable models.1, 23-25 Full 
definitions of covariates are listed in the supplementary file. These analyses were 
repeated for the secondary outcomes: mortality and myocardial infarction. The results of 
logistic regression analyses were presented as odds ratios (OR) with 95% confidence 
intervals. For the primary (MINS) analysis the available sample size was 15,109. Given a 
type I error rate of 5% and a background incidence of MINS of 7.9%, we have >99% 
power to detect a 1.8% absolute difference in the incidence of MINS for participants with 
intraoperative heart rate >100 bpm. The minimum sample size required to detect an 
absolute difference of 1.8% in the primary outcome, assuming a type I error rate of 5% 
and power of 99% is 4,967 participants. Additional power calculations for the secondary 
and tertiary outcomes are in the supplement. 
 
We suspected that any relationship between duration of intraoperative heart rate >100 
bpm / <55 bpm or systolic blood pressure >160 mmHg / <100 mmHg and MINS would 
be non-linear. Therefore, we stratified duration of intraoperative heart rate >100 bpm / 
<55 bpm or systolic blood pressure >160 mmHg / <100 mmHg into quartiles and 
repeated the primary multivariable logistic regression analysis for quartiles of duration 
and repeated as for the primary analysis. Quartiles of duration were considered as 
ordered categorical variables. The reference categories were patients with ‘normal’ heart 
rate or systolic blood pressure, for example in the analysis of duration of heart rate >100 
bpm, the reference group was patients with heart rate ≤100 bpm. We undertook post-hoc 
Bonferroni corrections to adjust for multiple comparisons. We were interested to see 
whether at least one episode (a single measurement) of ‘abnormal’ heart rate and at 
least one episode of ‘abnormal’ systolic blood pressure during the same operative 
episode influenced the degree of association with MINS. We therefore undertook a 
planned sensitivity analysis to examine the relationship between MINS and combinations 
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of abnormal heart rate and systolic blood pressure during a single surgical procedure; 
since the data were not time-stamped, these were not necessarily 
concurrent/simultaneous episodes. We categorized the cohort according to 
combinations highest/lowest heart rate and highest/lowest systolic blood pressure: 
highest heart rate and highest systolic blood pressure / highest heart rate and lowest 
systolic blood pressure / highest systolic blood pressure and lowest heart rate / lowest 
systolic blood pressure and lowest heart rate. We repeated primary statistical analysis 
using these categorical variables. 
 
Sensitivity analyses 
To determine the influence of emergency surgery, we excluded all emergency cases and 
repeated the primary analyses. To determine the influence of atrial fibrillation, we 
repeated the primary heart rate analyses after excluding all cases with a previous history 
of atrial fibrillation. To determine the influence of heart rate modulating medications - 
beta-adrenoceptor antagonists (beta-blockers) and calcium channel blockers (diltiazem 
and verapamil) - we excluded patients that received a beta-blocker and/or a calcium 
channel blocker within 24 hours before surgery and repeated the primary analysis of 
heart rate. In the primary analysis the independent variables were high/low heart 
rate/systolic blood pressure categorised according to one or more episodes above 
/below pre-defined binary thresholds. However, this did not take account of instances 
where a patient had both high and low heart rate/systolic blood pressure episodes during 
surgery. Therefore we undertook a post-hoc sensitivity analysis. Heart rate was 
categorized as: 55-100 bpm, minimum heart rate < 55 bpm, maximum heart rate > 100 
bpm, minimum heart rate < 55bpm and maximum heart rate > 100 bpm. Systolic blood 
pressure was categorized as: 100 – 160 mmHg, minimum systolic pressure < 100 
mmHg, maximum systolic pressure > 160 mmHg, minimum systolic pressure < 100 
mmHg and maximum systolic pressure > 160 mmHg. We repeated the primary analysis 
to test for association between these four-level heart rate/systolic blood pressure 
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16,079 patients were recruited to the VISION study from twelve hospitals in eight 
countries between 6th August 2007 and 11th January 2011.1 1,197/15,109 patients 
(7.9%) sustained MINS, 454/16,031 patients (2.8%) sustained MI and 315/16,061 
patients (2.0%) died, within 30 days of surgery. Baseline characteristics and simple 
frequencies and proportions of the main outcomes, stratified by the exposures of 
interest, are presented in table 1. Cases included in multivariable analyses are shown in 
figure 1. 
 
Intraoperative heart rate 
Highest intraoperative heart rate >100 bpm was associated with increased odds of 
MINS (OR 1.27 [1.07 – 1.50]; p <0.01), myocardial infarction (OR 1.34 [1.05 – 1.70]; 
p=0.02) and mortality (OR 2.65 [2.06 – 3.41]; p <0.01). Lowest intraoperative heart rate 
<55 bpm was associated with reduced odds of MINS (OR 0.70 [0.59 – 0.82]; p <0.01), 
myocardial infarction (OR 0.75 [0.58 - 0.97]; p=0.03) and mortality (OR 0.58 [0.41 – 
0.81]; p <0.01) (table 2, figure 2 and supplementary tables 1 and 2). Duration of 
intraoperative heart rate >100 bpm for longer than 30 minutes was associated with 
MINS (OR 2.22 [1.71 – 2.88]; p <0.01) compared to participants with intraoperative hart 
rate ≤100 bpm throughout the procedure (figure 3 and supplementary table 3). Heart 
rate <55 bpm for any duration was associated with reduced odds of MINS and there 
was a trend towards reduced likelihood of MINS as duration of heart rate < 55bpm 
increased (figure 3 and supplementary table 4).  
 
Intraoperative systolic blood pressure 
Highest intraoperative systolic blood pressure >160mmHg was associated with 
increased odds of MINS (OR 1.16 [1.01 – 1.34]; p=0.04) and myocardial infarction (OR 
1.34 [1.09 – 1.64]; p=0.01) and reduced odds of mortality (OR 0.76 [0.58 – 0.99]; 
p=0.04). Lowest intraoperative systolic blood pressure <100mmHg was associated with 
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increased odds of MINS (OR 1.21 [1.05 – 1.39]; p=0.01) and mortality (OR 1.81 [1.39 – 
2.37]; p <0.01), but was not associated with myocardial infarction (OR 1.21 [0.98-1.49]; 
p=0.07) (table 2, figure 2 and supplementary tables 5 and 6). Duration of systolic blood 
pressure >160 mmHg was not associated with MINS (figure 3 and supplementary table 
7). In comparison, duration of systolic blood pressure <100 mmHg for <15 minutes or 
>61 minutes was associated with MINS (OR 1.26 [1.04-1.54]; p=0.02 and OR 1.33 
[1.08-1.64]; p<0.01 respectively) (figure 3 and supplementary table 8). 
 
Intraoperative heart rate and systolic blood pressure 
Combinations of highest/lowest heart rate (HR) and systolic blood pressure (SBP) were 
categorised as: highest HR and highest SBP / highest HR and lowest SBP/ highest 
SBP and lowest HR / lowest SBP and lowest HR. The association between heart rate 
(HR) and MINS was modified by systolic blood pressure (SBP); shown in figure 4 and 
supplementary tables 9-12. The incidence of MINS in patients with hypotension (SBP 
<100 mmHg) and tachycardia (HR >100bpm) was 176/1906 (9.2%) and had higher 
odds of MINS (OR 1.42 [1.15-1.76]; p<0.01), compared to patients with hypotension in 
the absence of tachycardia (499/6632 [7.5%]; OR 1.20 [1.03-1.40]; p=0.02) or patients 
with tachycardia in the absence of hypotension (76/736 [10.3%]; OR 1.26 [0.94-1.69]; 
p=0.13), where the reference group was patients without hypotension or tachycardia. 
Patients with hypertension (SBP >160 mmHg) without bradycardia (HR <55 bpm) were 
at increased risk of MINS (326/2802 [11.6%]; OR 1.22 (1.04-1.43); p=0.02). However, 
bradycardia was associated with less risk of MINS, regardless of highest systolic blood 
pressure (figure 4). A similar result was seen for hypotension with and without 
bradycardia (figure 4). On post-hoc testing there was little evidence of statistical 
interaction (effect modification) between heart rate and blood pressure, except between 
elevated systolic pressure and elevated heart rate, where the association between 





When we repeated the primary analyses excluding 1828 participants undergoing 
emergency surgery, our results were similar (supplementary tables 13-16). When we 
repeated the primary heart rate analysis excluding 2727 participants that received 
either a beta-blocker or rate-limiting calcium channel blocker within 24 hours before 
surgery, our results were very similar (supplementary tables 17 and 18). However, the 
association between the lowest intraoperative heart rate <55 bpm and reduced 
mortality was no longer statistically significant (OR 0.71 [0.49 – 1.03]; p=0.07). When 
we repeated the primary heart rate analysis excluding 545 participants with pre-existing 
atrial fibrillation, our results were very similar (supplementary tables 19 and 20). 
However, the association between highest intraoperative heart rate >100 bpm was only 
a trend (OR 1.29 [0.99 – 1.67]; p=0.06). It is possible that a patient could have episodes 
of both high heart rate and low heart rate during the surgical procedure. The same is 
true for systolic blood pressure. We undertook a post hoc analysis that categorised 
episodes of high/low heart rate/systolic blood pressure into two four-level categorical 
variables (heart rate: 55-100 bpm / <55 bpm / >100 bpm / <55 and >100 bpm; and 
systolic blood pressure: 100 – 160 mmHg / <100 mmHg / >160 mmHg / <100 and >160 
mmHg) shown in supplementary table 21. The results were similar to the primary 
analysis (supplementary tables 22 and 23), except that the association between 
maximum systolic blood pressure >160 mmHg and MINS was no longer statistically 
significant (OR 1.22 [0.97-1.52]; p=0.08). The combination of minimum systolic 
pressure <100 mmHg and maximum systolic pressure >160 mmHg was associated 
with MINS (OR 1.42 [1.16-1.75]; p<0.01). However, the combination of minimum heart 
rate <55 bpm and maximum heart rate >100 bpm was not associated with MINS (OR 
0.70 [0.44-1.13]; p=0.15). To account for possible increased type I error associated with 
multiple comparisons in the analysis of duration of high/low HR/SBP quartiles, we 
undertook Bonferroni corrections. The results remained similar in that the longest 
durations of SBP <100 mmHg (>61 minutes), HR >100 bpm (>30 minutes) and HR <55 
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bpm (>55 minutes) remained associated with MINS. However, the associations 








The principal finding of this analysis is that intraoperative tachycardia and hypotension 
are independently associated with MINS and mortality. For the first time, we demonstrate 
the effect of combinations of intraoperative heart rate and systolic blood pressure. Our 
results suggest that the association between low systolic blood pressure and MINS is 
increased if elevated heart rate occurred during the procedure and reduced if low heart 
rate occurred during the procedure. Prolonged durations of heart rate > 100bpm and 
systolic blood pressure < 100mmHg were associated with increased risk of MINS. 
Furthermore, minimum intraoperative heart rate < 55bpm was associated with reduced 
risk of MINS and mortality. 
 
Our results are consistent with studies that demonstrate association between 
intraoperative hypotension and postoperative adverse events following non-cardiac 
surgery.7, 8, 12, 15, 26, 27 However, unlike our study, these were small and few used objective 
biomarkers as outcome measures. This is the first study to identify relationships between 
high intraoperative heart rate/systolic blood pressure and increased risk of MINS, and 
low intraoperative heart rate and reduced risk of MINS. While the observational nature of 
our data do not allow us to infer causal relationships, it is reasonable to hypothesize that 
active avoidance of either very high heart rate, or very high/low systolic blood pressures 
during surgery may be clinically beneficial. Data from clinical trials suggest that treatment 
with beta-blockers (which lower heart rate) can reduce the risk of myocardial infarction 
after non-cardiac surgery, but at the expense of larger increases in the risk of mortality 
and stroke.12, 28 However, it is difficult to disentangle the effect of heart rate from the 
effect of beta-blockers and the degree of interaction between these variables. In our 
study, 2,727 (16.9%) patients received a beta-blocker or negatively chronotropic calcium 
channel blocker within 24 hours before surgery. We repeated the primary analysis after 
removing these cases and found that the association between maximum intraoperative 
heart rate and all the outcomes, and between minimum intraoperative heart rate and 
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MINS/myocardial infarction were unchanged. However, the negative association 
between minimum intraoperative heart rate <55bpm and mortality was no longer 
statistically significant. In other words, the ‘protective’ association between low heart rate 
and reduced risk of mortality was lost in patients not receiving a beta-blocker or calcium 
channel antagonist. We previously made a similar observation for low preoperative heart 
rate, which suggests confounding by rate-controlling medication.11 However, we are 
unable to infer a causative relationship due to the observational nature of our data. This 
contrasts with the results of previous clinical trials where heart rate lowering medication 
was associated with increased mortality.12 Further research is needed to investigate 
potential mechanisms underlying this observation, in addition to trials targeting heart rate 
control while avoiding hypotension.29 
 
Our data suggest that very high or very low intraoperative heart rate and blood pressure 
are key perioperative factors that, alone or in tandem, may contribute to MINS. The 
potential for preoperative identification or treatment of these patients needs further 
research.30, 31 The pathophysiological mechanism of MINS is unclear. It may be caused 
by extended periods of myocardial ischemia as a result of oxygen supply-demand 
imbalance in cardiac muscle; the proposed mechanism of type 2 myocardial infarction.9, 
32 In the context of this model, intraoperative hypotension or tachycardia may reduce 
myocardial perfusion pressure leading to reduced myocardial oxygen supply. Similarly, 
elevated systolic pressure increases end-systolic stress, leading to increased myocardial 
oxygen demand.33 Our results support this theory; we observed increasing risk of MINS 
as the duration of tachycardia or hypotension increased. This is consistent with animal 
studies of tachycardia induced sub-endocardial myocardial necrosis, where the duration 
ischemia was correlated with degree of necrosis.34 In addition, we observed that patients 
with very high and very low blood pressure during surgery were at greater risk of MINS 
than either high or low blood pressure alone. While we adjusted our analysis for multiple 
perioperative factors, our findings may reflect unmeasured confounding and cannot 
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exclude that tachycardia/hypertension/hypotension are merely markers of other 
conditions or treatment interventions that may promote MINS.35-39  
 
A strength of this analysis is the large sample size derived from multiple centres in 
multiple countries, giving robust external validity and making our results generalisable to 
the vast majority of patients undergoing non-cardiac surgery. The primary outcome was 
an objective biomarker, rather than a potentially subjective, clinically defined outcome. 
The use of troponin is important because more than four out five patients with MINS are 
asymptomatic, while only one third have electrocardiographic or echocardiographic 
evidence of ischemia.19 The detailed nature of the VISION database allowed us to adjust 
our analysis for confounding factors using multivariable regression modelling, including 
pre-existing atrial fibrillation.  
 
Our analyses also have some important limitations. We cannot exclude unmeasured 
confounding, for example; the use of intraoperative cardiac medication, the presence of 
cardiac pacemakers and the incidence of preoperative troponin elevation are all 
unknown, although we expect the frequency of these to be low.40, 41 Similarly, we did not 
routinely seek evidence of myocardial ischemia in patients with troponin elevation <0.04 
ng/mL, which may underestimate the incidence of myocardial ischemia. Another 
potentially confounding factor is pre-existing atrial fibrillation, which we corrected for by 
inclusion in the multivariable models and through sensitivity analysis. We performed 
additional sensitivity analyses that excluded cases of emergency surgery, and patients 
receiving preoperative beta-blockers or rate limiting calcium channel antagonists within 
24 hours before surgery. However, in the case of rate limiting medication, it is possible 
that the sensitivity analysis included patients that stopped taking these medications, with 
a variety of half-lives, > 24 hours before surgery. It is possible that the type of anesthesia 
(volatile, intravenous, balanced or regional techniques) could have confounded our 
results, however these data were not available for this secondary analysis, so we were 
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unable to undertake a post-hoc sensitivity analysis on this basis. Continuous 
measurements of intraoperative heart rate and blood pressure were not recorded as part 
of this study; therefore our analysis was limited to summary data for intraoperative heart 
rate blood pressure, which included pre-defined thresholds. Similarly, it is unclear why 
systolic blood pressure <100 mmHg for between 15 and 60 minutes was not associated 
with MINS. Future computational research using continuously recorded heart rate or 
blood pressure data should be considered. We could only adjust the analysis for the 
absolute duration of intraoperative tachycardia/hypotension rather than expressing this 
as a proportion of length of surgery. We undertook a planned sensitivity analysis to 
examine association between combinations of abnormal intraoperative heart rate and 
systolic blood pressure and MINS, and a post-hoc analysis of combinations of very high 
and very low blood pressure/heart rate during surgery and MINS. However, since our 
data did not include the exact timing of high/low heart rate/systolic blood pressure, these 
combinations were not necessarily concurrent/simultaneous episodes. Our data suggest 
that future research to examine contemporaneous episodes of abnormal heart rate and 
systolic blood pressure is warranted, particularly the combination of tachycardia and 
hypotension. 
 
Very high heart rate and very high or low systolic blood pressure during surgery are 
associated with increased risk of myocardial injury after non-cardiac surgery. The 
duration of low intraoperative blood pressure and high heart rate are additional 
aetiological factors for MINS. Further targeted interventional studies using intraoperative 
heart rate and/or blood pressure thresholds that we have identified may help identify 
strategies to reduce perioperative cardiac complications.   
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Intraoperative	HR	or	SBP	groups	 Whole	cohort	 HR	>100	 HR	<55	 SBP	>160	 SBP	<100	
Number	of	cases	(n)	 16079	 2936	 4256	 4754	 9891	
Mean	age	(SD)	 65	(11.9)	 64	(12.3)	 65	(11.3)	 68	(11.6)	 64	(11.6)	
Sex	
	 	 	 	 	Male	(%)	 7763	(48.3) 1448	(49.3) 2118	(49.8) 2197	(46.2) 4702	(47.5)
Female	(%)	 8316	(51.7)	 1488	(50.7)	 2138	(50.2)	 2557	(53.8)	 5189	(52.5)	
Comorbid	disorder	(%)	
	 	 	 	 	Atrial	fibrillation	 545	(3.4) 142	(4.8) 106	(2.5) 171	(3.6) 281	(2.8)
Diabetes	 3153	(19.6)	 626	(21.3)	 744	(17.5)	 1163	(24.5)	 1785	(18.0)	
Hypertension	 8171	(50.8)	 1304	(44.4)	 2226	(52.3)	 2844	(59.8)	 4754	(48.1)	
Congestive	cardiac	failure	 761	(4.7)	 121	(4.1)	 184	(4.3)	 256	(5.4)	 405	(4.1)	
Coronary	artery	disease	 1947	(12.1)	 247	(8.4)	 608	(14.3)	 674	(14.2)	 1054	(10.7)	
Peripheral	vascular	disease	 858	(5.3)	 127	(4.3)	 238	(5.6)	 316	(6.6)	 421	(4.3)	
Previous	stroke	or	transient	ischemic	attack	 1167	(7.3)	 279	(9.5)	 317	(7.5)	 533	(11.2)	 643	(6.5)	
Chronic	obstructive	pulmonary	disease	(COPD)	 1337	(8.3)	 205	(7.0)	 269	(6.3)	 396	(8.3)	 797	(8.1)	
Preoperative	eGFR	(%)	
	 	 	 	 	<30	ml/min	 564	(3.5) 131	(4.7) 104	(2.6) 195	(4.3) 311	(3.4)
30-45	ml/min	 831	(5.2)	 171	(6.1)	 224	(5.7)	 336	(7.4)	 459	(5.0)	
45-60	ml/min	 1579	(9.8)	 241	(8.6)	 457	(11.5)	 592	(13.0)	 904	(9.9)	
>60	ml/min	 11938	(74.2)	 2254	(80.6)	 3179	(80.2)	 3416	(75.3)	 7483	(81.7)	
Surgical	procedure	category	(%)	
	 	 	 	 	Elective	 13765	(85.6) 2312	(78.7) 3881	(91.2) 4020	(84.6) 8512	(86.1)
Urgent	 485	(3.0)	 162	(5.5)	 83	(2.0)	 170	(3.6)	 317	(3.2)	
Emergency	 1828	(11.4)	 462	(15.7)	 292	(6.9)	 564	(11.9)	 1062	(10.7)	
Major	surgery	(%)	 9600	(59.7)	 1774	(60.4)	 2477	(58.2)	 2956	(62.2)	 6075	(61.4)	
Outcome	measures	(%)	
	 	 	 	 	MINS	 1197	(7.4) 257	(9.7) 233	(5.8) 436	(10.0) 711	(7.7)
Myocardial	Infarction	 454	(2.8)	 109	(3.7)	 88	(2.1)	 185	(2.8)	 276	(2.8)	









the	 reference	 category.	 Lowest	 intraoperative	 systolic	 blood	 pressure	was	 dichotomized	 according	 to	 the	 threshold	 of	 <100	mmHg	with	 systolic	 blood	 pressure	 ≥100	mmHg	 as	 the	
reference	category.	Results	of	adjusted	analyses	are	presented	with	unadjusted	analyses	for	comparison.	Full	multi-variable	models	are	presented	in	supplementary	tables	1-4.		
		 MINS	 Myocardial	Infarction	 Mortality	
Covariates	 odds	ratio	 p-value	 odds	ratio	 p-value	 odds	ratio	 p-value	
Highest	intraoperative	heart	rate	>100	bpm	
	 	 	 	 	 	Unadjusted	 1.31	(1.14-1.52)	 <0.01	 1.42	(1.15-1.78)	 <0.01	 2.79	(2.21-3.51)	 <0.01	
Adjusted	 1.27	(1.07-1.50)	 <0.01	 1.34	(1.05-1.70)	 0.02	 2.65	(2.06-3.41)	 <0.01	
	 	 	 	 	 	 	Lowest	intraoperative	heart	rate	<55	bpm	
	 	 	 	 	 	Unadjusted	 0.66	(0.57-0.76)	 <0.01	 0.66	(0.52-0.84)	 <0.01	 0.51	(0.37-0.69)	 <0.01	
Adjusted	 0.70	(0.59-0.82)	 <0.01	 0.75	(0.58-0.97)	 0.03	 0.58	(0.41-0.81)	 <0.01	
	 	 	 	 	 	 	
Highest	intraoperative	systolic	blood	pressure	>160	mmHg	 	 	 	 	 	 	
Unadjusted	 1.48	(1.30-1.67)	 <0.01	 1.67	(1.38-2.03)	 <0.01	 0.96	(0.75-1.23)	 0.75	
Adjusted	 1.16	(1.01-1.34)	 0.04	 1.34	(1.09-1.64)	 0.01	 0.76	(0.58-0.99)	 0.04	
	 	 	 	 	 	 	
Lowest	intraoperative	systolic	blood	pressure	<100mmHg	 	 	 	 	 	 	
Unadjusted	 0.94	(0.83-1.06)	 0.28	 0.97	(0.80-1.17)	 0.72	 1.49	(1.16-1.91)	 <0.01	
Adjusted	 1.21	(1.05-1.39)	 0.01	 1.21	(0.98-1.49)	 0.07	 1.81	(1.39-2.37)	 <0.01	

















myocardial	 infarction	 and	mortality	within	 30	 days	 after	 surgery.	 Highest	 intraoperative	 heart	
rate	was	dichotomized	according	to	a	threshold	of	>100	beats	per	minute	(bpm)	with	heart	rate	
≤100	 bpm	 as	 the	 reference	 category.	 Lowest	 intraoperative	 heart	 rate	 was	 dichotomized	












Figure	 3.	 Forest	 plot	 summarizing	 multivariable	 logistic	 regression	 models	 for	 the	 duration	 of	
high/low	intraoperative	heart	rate	(HR)	and	systolic	blood	pressure	(SBP).	The	dependent	variable	
was	MINS	within	30	days	after	surgery.	There	were	four	separate	regression	models	for	duration	
of:	 intraoperative	 heart	 rate	 >100	 beats	 per	 minute	 (bpm),	 intraoperative	 heart	 rate	 <55	 bpm	
intraoperative	systolic	blood	pressure	>160	mmHg	and	intraoperative	systolic	blood	pressure	<100	










Figure	 4.	 Forest	 plot	 summarizing	multivariable	 logistic	 regression	models	 for	 combinations	 of	
highest/lowest	 intraoperative	systolic	blood	pressure	(SBP)	and	heart	rate	(HR).	The	dependent	
variable	was	MINS	within	30	days	after	surgery.	The	sample	was	categorized	according	to	highest	
intraoperative	systolic	blood	pressure	(SBP)	>160	mmHg,	lowest	intraoperative	SBP	<100	mmHg,	
highest	intraoperative	heart	rate	(HR)	>100	beats	per	minute	(bpm)	and	lowest	intraoperative	HR	
<55	bpm.	For	highest	SBP	and	HR	the	reference	group	was	SBP	≤160	&	HR	≤100,	for	lowest	SBP	
and	highest	HR	the	reference	group	was	SBP	≥100	&	HR	≤100,	for	highest	SBP	and	lowest	HR	the	
reference	group	was	SBP	≤160	&	HR	≥55	and	for	lowest	SBP	and	lowest	HR	the	reference	group	
was	SBP	≥100	&	HR	≥55.	The	x-axis	shows	odds	ratios	and	the	error	bars	show	95%	confidence	
intervals.	The	results	presented	are	summaries	of	adjusted	analyses	(as	per	the	primary	analysis).	
Full	multi-variable	models	are	presented	in	supplementary	tables	9-12.		
	
